Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe or pyridoxine in patients with primary biliary cirrhosis
2006-006742-34Phase 4Terminated
- Sponsor
- Barts Health NHS Trust
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ezetimibe in primary biliary cholangitis (PBC) (2 arms), sponsored by Barts Health NHS Trust. Primary endpoint: Change in plasma total cholesterol concentration. Started Jun 2007; status: terminated.
02
Drugs
ezetimibe
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on 2006-006742-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006742-34.